Collectively, these findings suggest that CD4+ T cells and the PD-1+ CD4+ T cell subset may have a more important effector function in CTCL than previously appreciated, in line with prior observations in Hodgkin lymphoma47. This evidence concerns the gene PDCD1 and primary cutaneous T-cell non-Hodgkin lymphoma.